Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Three-Compartment Open Model01:06

Three-Compartment Open Model

421
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
421
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Two-Compartment Open Model: Extravascular Administration01:12

Two-Compartment Open Model: Extravascular Administration

319
The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
319
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

108
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
108
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

140
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
140

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

In situ characterization of aerosol deposition in dry powder inhalers using optical coherence tomography.

International journal of pharmaceutics·2026
Same author

Proteomic profiling of metabolizing enzymes and transporters in 2 layers of Caucasian human skin.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Influence of inflammation on drug transporter expression in human airway epithelia: Implications for inhaled drug pharmacokinetics.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Regional Nasal Drug Deposition in Pediatric vs. Adult Models: In vitro Insights into User Technique and Breathing Patterns Sensitivity.

Pharmaceutical research·2026
Same author

Mechanistic modeling of amyloid dynamics relating to Alzheimer's disease progression.

Frontiers in aging neuroscience·2026
Same author

Modeling lung transporters and their influence on inhaled drug disposition.

Pharmacological reviews·2025

関連する実験動画

Updated: Sep 10, 2025

Development of an In Vitro Ocular Platform to Test Contact Lenses
08:28

Development of an In Vitro Ocular Platform to Test Contact Lenses

Published on: April 6, 2016

10.7K

人間の涙膜における眼滴分布を予測するための準3Dメカニズムモデル

Harsha T Garimella1, Carly Norris1, Carrie German1

  • 1Biomedical, Energy, and Materials Division, CFD Research Corporation, 6820 Moquin Drive NW, Huntsville, AL 35806, USA.

Bioengineering (Basel, Switzerland)
|August 28, 2025
PubMed
まとめ

新しい準3D (Q3D) 涙膜モデルは,瞬きと排水を組み込むことで眼薬投与シミュレーションを強化します. この高速な計算モデルにより 緑内障や乾燥眼などの 薬剤吸収の予測が改善されます

キーワード:
瞬くデキサメタゾン排水眼ドロップ速く走る準3D涙フィルム

さらに関連する動画

Establishment of A Mouse Model of Aqueous Deficiency Dry Eye
05:21

Establishment of A Mouse Model of Aqueous Deficiency Dry Eye

Published on: November 1, 2024

745
Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
06:29

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation

Published on: May 2, 2020

3.9K

関連する実験動画

Last Updated: Sep 10, 2025

Development of an In Vitro Ocular Platform to Test Contact Lenses
08:28

Development of an In Vitro Ocular Platform to Test Contact Lenses

Published on: April 6, 2016

10.7K
Establishment of A Mouse Model of Aqueous Deficiency Dry Eye
05:21

Establishment of A Mouse Model of Aqueous Deficiency Dry Eye

Published on: November 1, 2024

745
Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
06:29

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation

Published on: May 2, 2020

3.9K

科学分野:

  • 眼薬学とコンピュータモデリング
  • 生物医学工学と薬物投与システム

背景:

  • 眼部への局所投与は グラウコマや乾燥眼の治療に不可欠です
  • 生理学に基づく薬動力学 (PBPK) モデリングは薬剤の有効性を予測しますが,しばしば高解像度で時間がかかるシミュレーションが必要です.
  • 既存のモデルには 涙膜環境の詳細なメカニズムが欠けています

研究 の 目的:

  • 人間の涙膜の急速な準3D (Q3D) 計算モデルを開発する.
  • 眼薬投与シミュレーションに点滅,排水,吸収,蒸発などの重要なメカニズム的要因を組み込む.
  • 眼中の薬物の分布と吸収を予測する精度と効率を向上させる.

主な方法:

  • 人間の涙膜の準3D (Q3D) 計算モデルを開発した.
  • フリッドフロー,吸収,排水,蒸発をモデルに統合した.
  • 高解像度コンパートメントモデルと通常の微分方程式 (ODEs) を使用して量化された平均薬剤吸収.
  • 局所用デキサメタゾンサスペンションの実験データに対する検証されたシミュレーション

主要な成果:

  • Q3Dティアーフィルムモデルは,瞬きのメカニズムと流れの分布をうまくシミュレートしました.
  • モデルの予測は,薬物の吸収に関する実験データと良好な一致を示した (R2 = 0. 76).
  • 予測の精度を維持しながら,計算時間 (CPU時間) を大幅に削減しました.

結論:

  • 開発されたQ3D涙膜モデルは,局所眼薬の投与をシミュレートするための計算的に効率的で正確なツールを提供します.
  • このモデルは,以前は高速走行シミュレーションで省略された重要な生理学的要因を考慮します.
  • 全身PBPKモデルにシームレスに統合し,眼科治療の開発を進めます.